Skip to main content
. Author manuscript; available in PMC: 2016 Jul 3.
Published in final edited form as: J Med Virol. 2014 Jun 4;86(9):1507–1514. doi: 10.1002/jmv.23987

Fig. 4.

Fig. 4

Serial miR-122 and hgDNA values across treatment time points for patients undergoing hepatitis C treatment. A: Log miR-122 levels across treatment time points. Median values decrease following Week 1, and are significantly lower at sustained viral response. B: Serial Log10 hgDNA levels across treatment time points. No significant differences were observed in hgDNA levels. Plots presented using Tukey method.